7 completed, 4 unknown, 1 not yet recruiting, 1 recruiting. 4 Phase 2, 4 Phase 4, 3 Phase 3, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 4 | 4 | Unknown 2, Completed 1, Recruiting 1 |
| Phase 3 | 3 | Completed 2, Not yet recruiting 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Neuroaid: new trials by email Literature Review of Neuroaid trials Research Report on Neuroaid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke MLC901, Standard treatment for acute ischemic stroke - Stroke, Stroke, Acute Ischemic | Phase 4 | Recruiting | EVD Pharmacy and Medical Company Limited | 80 | 2026-09-10 | 2026-10-20 |
| Alzheimer's Disease THErapy With NEuroaid II MLC 901, Placebo - Alzheimer's Disease Dementia | Phase 3 | Not yet recruiting | Moleac Pte Ltd. | 350 | 2026-08-01 | 2026-06-12 |
| NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury Traditional Chinese Medicine (NeuroAiD II™ (MLC901), Placebo - Traumatic Brain Injury | Phase 3 | Completed | Moleac Pte Ltd. | 182 | 2021-08-23 | 2023-03-15 |
| MLC901 in Moderate Traumatic Brain Injury MLC901, Placebo - Moderate Traumatic Brain Injury | Phase 4 | Unknown | University of the Philippines | 120 | 2021-05-01 | 2023-06-13 |
| MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial MLC 901, Placebo - Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest | Early Phase 1 | Completed | Shahid Beheshti University of Medical Sciences | 35 | 2020-03-10 | 2022-11-18 |
| MLC901 for Moderate to Severe Traumatic Brain Injury (Specified Drug Code) MLC901 or Placebo - Traumatic Brain Injury | Phase 4 | Unknown | Ali Amini Harandi | 80 | 2018-08-20 | 2020-07-27 |
| The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study MLC901, Placebo - Alzheimer Disease | Phase 2 | Unknown | National University Hospital, Singapore | 150 | 2016-12-01 | 2017-01-31 |
| Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD NeuroAiD - Spinal Cord Injury | Phase 4 | Completed | Moleac Pte Ltd. | 30 | 2015-04-01 | 2024-03-15 |
| NeuroAiD Safe Treatment Registry NeuroAiD - Brain Injury, NeuroAiD Use | Unknown | CHIMES Society | 2000 | 2014-06-01 | 2023-02-17 | |
| NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects MLC901, Placebo - Cognitive Impairment | Phase 2 | Completed | National University Hospital, Singapore | 103 | 2013-03-01 | 2018-07-27 |
| Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine MLC601 - Alzheimer Disease | Phase 2 | Completed | Shahid Beheshti University of Medical Sciences | 125 | 2011-01-01 | 2012-09-28 |
| Study of NeuroAid In Enhancing Recovery After Stroke Neuroaid, Neuroaid matched Placebo - Stroke, Cerebral Infarction | Phase 2 | Completed | Moleac Pte Ltd. | 40 | 2008-01-01 | 2008-07-24 |
| CHInese Medicine NeuroAid Efficacy on Stroke Recovery NeuroAid, NeuroAid matched Placebo - Cerebral Infarction, Stroke | Phase 3 | Completed | CHIMES Society | 1100 | 2007-05-01 | 2014-05-01 |
Alzheimer Disease (3) · Stroke (3) · Brain Injuries, Traumatic (2) · Cerebral Infarction (2) · Brain Injuries (1) · Cognitive Dysfunction (1) · Ischemic Stroke (1) · Myocardial Infarction (1) · Spinal Cord Injuries (1)
Moleac Pte Ltd. (4) · CHIMES Society (2) · National University Hospital, Singapore (2) · Shahid Beheshti University of Medical Sciences (2) · Ali Amini Harandi (1) · EVD Pharmacy and Medical Company Limited (1) · University of the Philippines (1)
Singapore (5) · Iran (3) · Malaysia (3) · Philippines (3) · Vietnam (2) · Hong Kong (1) · Indonesia (1) · Russia (1) · Sri Lanka (1) · Thailand (1)
Ali Amini, M.D (1) · Annabell E Chua, MD (1) · Christopher Chen, MBBS (1) · Christopher LH Chen, FRCP (1) · Christopher Li Hsian Chen (1) · Keng He Kong, MD (1) · Lyna Soertidewi, MD (1) · Marie Germaine Bousser, MD (1) · Narayanaswamy Venketasubramanian, FRCP (1) · Ramesh Kumar, FRCS (1)
PMID 23780952, PMID 24135924, PMID 26567259, PMID 26628386, PMID 27919862, PMID 34856171, PMID 35418437, PMID 35604343, PMID 36843256, PMID 37129384, PMID 39334395, PMID 40638707